Since 2000, more than 40% of cancer-fighting therapies approved by the FDA were first approved to treat blood cancer patients and many of these therapies are now helping patients with non-blood cancers. Some of the approved therapies are chemotherapy, bone and stem cell transplantation, and more recently immunotherapy.
An estimated 186,400 people in the US are expected to be diagnosed with leukemia, lymphoma or myeloma in 2021. Within the last ten years, blood cancer survival rates have doubled, tripled, or quadrupled depending on the specific cancer. An estimated 1,361,567 people in the US are either living with, or are in remission from, leukemia, lymphoma or myeloma.
The Seattle Big Climb started in 1986 and has contributed to LLS generating over $26 million in funding for research. In 2018 the Seattle Big Climb broke the $3 million dollar barrier for a single year. Seattle is joined by ten other Big Climb events across the continental US.
Event Day: Sunday March 26, 2023
General Registration: September 29th, 2022 at 9:00 AM
There is a fundraising minimum of $150/person ($100/person for those 17 and under) to benefit the Leukemia & Lymphoma Society's mission to eradicate blood cancers. Please note: All participants must reach the fundraising minimum to climb on event day.
If you are interested in a corporate partnership with our event, please contact our Campaign Development Manager, Heather Danforth, at email@example.com or 206.957.45612023 Sponsors
If you are interested in volunteering for the event, please contact our interim Campaign Development Director, Jacquelyn Harvey, at firstname.lastname@example.org or 206.957.4574.Sign Up Here
If you are interested in photographing Big Climb, please contact the Big Climb staff here.
If you are with a media outlet and are interested in covering the Big Climb in some capacity, please contact our interim Campaign Development Director, Jacquelyn Harvey, at email@example.com or 206.957.4574.